Massimo Cristofanilli
0000-0002-4194-7175
Publication & Citation Trends
Most Cited Works
Publications
1,436 total
Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer PDF
Cited by 1,267
OpenAlex
The Genetic Landscape and Clonal Evolution of Breast Cancer Resistance to Palbociclib plus Fulvestrant in the PALOMA-3 Trial PDF
Cited by 656
OpenAlex
Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial
Cited by 1,800
OpenAlex
Plasma <i>ESR1</i> Mutations and the Treatment of Estrogen Receptor–Positive Advanced Breast Cancer
Cited by 704
OpenAlex
Emergence of Constitutively Active Estrogen Receptor-α Mutations in Pretreated Advanced Estrogen Receptor–Positive Breast Cancer
Cited by 652
OpenAlex
Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer PDF
Cited by 2,877
OpenAlex
Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch System
Cited by 1,332
OpenAlex
Research Topics
Cancer Cells and Metastasis
(490)
Cancer Genomics and Diagnostics
(455)
Advanced Breast Cancer Therapies
(245)
HER2/EGFR in Cancer Research
(218)
Breast Cancer Treatment Studies
(204)
Frequent Co-Authors
Affiliations
Université Paris-Sud
Rutgers, The State University of New Jersey
Università Cattolica del Sacro Cuore
Tunis University
Northwestern University